[Role of bone marrow graft in the treatment of acute lymphoblastic leukemias in children].
Schaison
G S
GS
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000276:immunology / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D006087:Graft vs Host Reaction / Q000502:physiology; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007223:Infant; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000601:surgery*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D006680:HLA Antigens; D003561:Cytarabine; D003520:Cyclophosphamide; D008558:Melphalan
Place de la greffe de moelle osseuse dans le traitement des leucémies aiguës lymphoblastiques de l'enfant.